top of page

Black Opal Ventures Founder, Eileen Tanghal, Serves as a Panelist at CSIS Global Security Forum 2024

Center for Strategic & International Studies held their Annual Global Security Forum last month featuring leaders in defense and national security communities across the public and private sectors.

In April, the Center for Strategic & International Studies (CSIS) held their Global Security Forum. The theme of this year's event is "Gathering Strength in a Gathering Storm." The event featured keynotes from Hon. Avril Haines, Director of National Intelligence, and General Charles Q. Brown Jr., Chairman of the Joint Chiefs of Staff, and several panels.  

Black Opal Ventures Founder, Eileen Tanghal, served on a panel titled “Gamechangers: Understanding the Convergence of Technologies and National Security Implications”. She was joined by fellow panelists Jacqueline Tame, Operating Partner at Playground Global and Executive Director of Silicon Valley Defense Group, Dr. Wendy Goodson, VP of Government Business Development at Ginkgo Bioworks, and moderator, Emily Harding, Director of Intelligence, National Security, and Technology Program as well as Deputy Director of International Security Program at CSIS. Together, the panelists discussed emerging technologies and the critical technologies for the future of defense and intelligence. Jacqueline discussed her work in quantum and the lack of principled understanding. She said, “it fills me with both hope and fear simultaneously that [quantum is the most cited critical technology].” 

Dr. Goodson and Eileen spoke to the lack of recognition of biotech and engineered biology as a critical technology despite the widespread and easily disseminated threat potential. Eileen said, “The fragmentation of the semiconductor industry is very similar to what is happening in the biotech world today and how we need to be excited about it but also very careful that there are not any chokepoints in the chain." The panelists reflected on the need to further collaboration between government, startups, and venture capitalists. Black Opal Ventures continues to invest in engineered biology as part of our 4D investment strategy (diagnostics, delivery of care, drug discovery, and data). Eileen shared the belief that Moore’s Law should be applied to healthcare and life sciences in that solutions are being brought to market that double the number of patients with improved outcomes at half the cost every two years. 

Watch the full panel here.

The CSIS Global Security Forum convenes leaders from the defense and national security communities to discuss the top security challenges facing the country and the world. Black Opal Ventures aims to improve health outcomes for all by investing in companies at the collision of healthcare and technology.   


bottom of page